Author Interviews, Bone Density, NEJM, Orthopedics / 21.12.2018
Reclast, Zometa (zoledronate) Reduced Fractures in Osteopenic Older Women
MedicalResearch.com Interview with:
[caption id="attachment_46675" align="alignleft" width="200"] Prof. Reid[/caption]
Prof Ian Reid MD
Faculty of Medical and Health Sciences
University of Auckland
Auckland New Zealand
MedicalResearch.com: What is the background for this study?
Response: Bisphosphonates prevent fractures in patients with osteoporosis, but their efficacy in women with osteopenia is unknown. Most fractures in postmenopausal women occur in osteopenic patients, so therapies with efficacy in osteopenia are needed.
Prof. Reid[/caption]
Prof Ian Reid MD
Faculty of Medical and Health Sciences
University of Auckland
Auckland New Zealand
MedicalResearch.com: What is the background for this study?
Response: Bisphosphonates prevent fractures in patients with osteoporosis, but their efficacy in women with osteopenia is unknown. Most fractures in postmenopausal women occur in osteopenic patients, so therapies with efficacy in osteopenia are needed.